News
DelveInsight's Merkel Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment ...
A phase 1b trial is evaluating PH-762 for the treatment of cutaneous squamous cell carcinoma, melanoma and Merkel cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback